Scholarly Index
Helena A. Yu
Memorial Sloan Kettering Cancer Center; 16,032 total citations; 327 total publications; best world rank #26
Memorial Sloan Kettering Cancer Center
16,032Total citations
327Total publications
56H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lung Cancer Treatments and Mutations | Lifetime | 334 | US 179 | 99.17 |
| Lung Cancer Research Studies | Lifetime | 270 | US 125 | 98.85 |
| Colorectal Cancer Treatments and Studies | Lifetime | 528 | US 228 | 98.43 |
| Cancer therapeutics and mechanisms | Lifetime | 515 | US 269 | 97.36 |
| HER2/EGFR in Cancer Research | Lifetime | 616 | US 280 | 97.53 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 39 | US 17 | 99.72 |
| Lung Cancer Research Studies | 2021-2025 | 26 | US 9 | 99.56 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 54 | US 21 | 99.12 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 273 | US 80 | 97.03 |
| HER2/EGFR in Cancer Research | 2021-2025 | 144 | US 53 | 97.89 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 504 | US 100 | 96.06 |
| Cancer Genomics and Diagnostics | 2021-2025 | 850 | US 367 | 95.05 |
| Brain Metastases and Treatment | 2021-2025 | 284 | US 151 | 92.40 |
| Cancer therapeutics and mechanisms | 2021-2025 | 847 | US 181 | 73.97 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 939 | US 317 | 59.98 |